GLPwatch
Trials (2139)
Page 8 of 36.
- Comparison of Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and Glimepiride as add-on Metformin
- Exenatide and Impaired Hypoglycaemic Awareness in Type 1 Diabetes
- A Multiple-Dose Study of LY3502970 in Healthy Participants
- A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec in Subjects With Type 2 Diabetes
- Clinical Study of Local and Systemic Biological Impact of GLP1/GIP-Receptor Agonists in Patients With Breast Cancer: The CLARA Trial
- Evaluation of Insulin Glargine/Lixisenatide Fixed Ratio Combination in Patients With Type 2 Diabetes Insufficiently Controlled With Oral Antidiabetic Drug(s)
- Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes
- Diabetes Islet Preservation Immune Treatment
- A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)
- Visualizing Beta Cells in Patients With a History of Gestational Diabetes
- Emulation of the SOUL Diabetes Trial in Healthcare Claims
- 68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of Nesidioblastosis
- A Study to Evaluate Safety, Tolerability and pK of Semaglutide ER Injectable Suspension in Healthy, Adult Human Subjects
- Weight Loss With Intensive Lifestyle Modifications Plus Bariatric Surgery Versus Liraglutide 3 mg
- Evaluation of the Efficacy and Safety of GLP-1 Receptor Agonist Therapy In Steroid-Induced Diabetes
- Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes
- A Study in People With Overweight or Obesity to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body
- Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 Diabetes
- SEMASEARCH, Retrospective/Prospective Cohort Nested at ATUc/AP2 WEGOVY®
- Multi-Site Trial of Tirzepatide for Smoking Cessation
- Effects of Exenatide on Overweight Adolescents With Prader-Willi Syndrome
- A Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes Mellitus
- Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403)
- Vildagliptin Versus Liraglutide - Patient Preference After Receiving Both Medications
- Effects of Degludec/Liraglutide on Time in Range, Inflammation and Endothelial Function vs Insulin Basal Bolus in Diabetic Inpatients
- a Study of JY09 in Chinese Healthy Subjects
- Researching an Effect of GLP-1 Agonist on Liver STeatosis (REALIST)
- Effect of Liraglutide on the Beta-cell Responsiveness in Subjects With Type 2 Diabetes Compared to a Healthy Control Group
- A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Israel, as Part of Local Clinical Practice
- Semaglutide and Structured Lifestyle Support to Improve Heart and Blood Vessel Health in Postmenopausal Obese Breast Cancer Survivors Taking Aromatase Inhibitors
- Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh
- Residual Gastric Content After Holding of Glucagon-like Peptide-1 Receptor Agonists Before Elective Surgery
- Comparison of Three Liraglutide Formulations in Healthy Volunteers
- IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion
- Weight Loss in Adults Using Semaglutide (Real-world Study)
- A Study of SRSD384 in Overweight or Obese Participants
- Exenatide in Extreme Pediatric Obesity
- Exploratory Study on the Efficacy and Safety of Semaglutide for Idiopathic Intracranial Hypertension Treatment
- Research Study to Look at How Well Semaglutide is at Lowering Weight When Taken Together With an Intensive Lifestyle Program
- RESTORE TRIAL: Study of the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)
- A Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly in Subjects With Type 2 Diabetes Mellitus (DURATION-5)
- Intravenous Exenatide (Byetta) During Surgery
- A Clinical Trial Looking at the Comparability of 2 Different Forms of Semaglutide
- The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study
- The Medically Reproducing Bariatric Surgery (MRB) II Study
- Semaglutide Treatment On Coronary Progression
- Feasibility of Semaglutide in Advanced Lung Disease
- Using Secondary Data to Evaluate Sex-based Heterogeneity of GLP-1 Agonists and SGLT2 Inhibitors on Cardiovascular-Kidney-Metabolic Health (CKMH) Outcomes in Real-world Settings (DASH-CKMH)
- A Study of LY3502970 in Healthy Overweight and Obese Participants
- Exenatide Once Weekly Over 2 Years as a Potential Disease Modifying Treatment for Parkinson's Disease
- Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease
- SR-Exenatide (PT320) to Eveluate Efficacy and Safety in Patients With Early Parkinson's Disease
- A Proof-of-Concept Study to Evaluate Topical-Lingual Semaglutide in Adults With Obesity
- Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight
- A Study of Bimagrumab Alone (LY3985863) and Bimagrumab With Tirzepatide (LY900042) in Healthy Participants
- Renal Effects of Treatment With Empagliflozin Alone or in Combination With Semaglutide in Patients With Type 2 Diabetes and Albuminuria
- Semaglutide in CFRD
- Latino Semaglutide Study
- Effect of Exenatide on 24h-UAER in Patients With Diabetic Nephropathy